[IKT] YoY Quarter Result on 31-Mar-2022 [#Q1]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
16-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 7.95%
YoY- -76.00%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 0 65 46 1,407 271 591 691 -
PBT -4,650 -4,478 -4,641 -2,637 -547 -1,736 -125 82.60%
Tax 0 -474 -4,641 -2,625 -540 -1,733 -12 -
NP -4,650 -4,003 -4,641 -2,637 -547 -1,736 -125 82.60%
Tax Rate - - - - - - - -
Total Cost 4,650 4,068 4,687 4,044 818 2,327 816 33.61%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 0.00 -6,204.86 -10,081.47 -187.40 -202.17 -293.75 -18.08 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.73 -0.87 -1.10 -1.57 -0.40 -1.27 -0.10 39.23%
EPS Diluted -0.73 -0.87 -1.10 -1.57 -0.40 -1.27 -0.10 39.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.